Roivant Sciences Ltd. · NASDAQ:ROIV

Venker Eric sold 200,000 Roivant Sciences Ltd. shares (Form 4)

Traded Jun 24, 2026 · Filed Jun 26, 2026

On Jun 24, 2026, Venker Eric (President & Immunovant CEO) sold 200,000 Roivant Sciences Ltd. shares at an average US$33.16 for US$6.63M under a trading plan, leaving 1,613,063 shares. Filed Jun 26, 2026 (Form 4).

Sold: 200,000 shares
Price: US$33.16 average (US$33.05 to US$33.51)
Value: US$6.63M
Holding after: 1,613,063 shares
Trading plan: Yes (Made under a plan set in advance)
Role: President & Immunovant CEO

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jun 24, 2026	Common Shares	Option exercise	200,000	US$3.85	1,813,063	Direct
Jun 24, 2026	Common Shares	Sale	153,766	US$33.05	1,659,297	Direct
Jun 24, 2026	Common Shares	Sale	46,234	US$33.51	1,613,063	Direct

Source

View original at SEC

Related